Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa

Tuberculosis patients in primary care do not start treatment. What role do health system delays play?

(2013) M. M. Claassens et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa

(2013) A. Van Rie et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment

(2013) J. Ho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting

(2013) M. Osman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnostic Implications of Inconsistent Results Obtained with the Xpert MTB/Rif Assay in Detection of Mycobacterium tuberculosis Isolates with an rpoB Mutation Associated with Low-Level Rifampin Resistance

(2013) A. Somoskovi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations

(2013) L. Rigouts et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

(2013) Grant Theron et al.   LANCET

Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa

(2013) Colleen F. Hanrahan et al.   PLoS One

Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a High Prevalence TB-HIV Region

(2013) Yacoob Mahomed Coovadia et al.   PLoS One

Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa

(2012) M. Loveday et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

(2012) F. K. Mukinda et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact [Correspondence]

(2012) Stephen D. Lawn et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

(2011) Grant Theron et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis

(2011) D. A. Williamson et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

(2011) Catharina C Boehme et al.   LANCET

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

(2011) Stephen D. Lawn et al.   PLOS MEDICINE

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

(2010) Catharina C. Boehme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results

(2009) A. Van Deun et al.   JOURNAL OF CLINICAL MICROBIOLOGY

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response

(2009) Salim S Abdool Karim et al.   LANCET